Navigation Links
Statement From The Pew Charitable Trusts on the U.S. Food and Drug Administration's Reversal on Antibiotics Safeguards in Animal Farming
Date:12/12/2008

WASHINGTON, Dec. 12 /PRNewswire-USNewswire/ -- Laura Rogers, project director for the Pew Campaign on Human Health and Industrial Farming, today issued the following statement regarding the U.S. Food and Drug Administration's decision to reverse its plan to ban off-label usage of certain antibiotics in animal agriculture:

"The misuse of antibiotics in animal agriculture helps fuel the increase in antibiotic-resistant infections - a fact long acknowledged by the American Medical Association, U.S. Centers for Disease Control and Prevention and even the FDA. Yet in another set-back for public health, the FDA reversed itself on the off-label use of cephalosporin - a family of antibiotics vitally important in human medicine - allowing this unrestricted use in industrial farm animal production to continue.

"Earlier this year, the agency had announced plans to ban all off-label uses in agriculture of these critical human drugs. Regrettably, the FDA changed its course.

"These important drugs are the only effective therapies for serious gastrointestinal diseases in children and also the best treatment for antibiotic-resistant infections in cancer patients. Easing restrictions on the use of cephalosporin on factory farms jeopardizes the effectiveness of these drugs and needlessly imperils our public health.

"In addition, the overuse of human antibiotics in farm animals is driving up the cost of healthcare. For example, in 1998 the Institute of Medicine estimated that antibiotic-resistant bacteria generated an estimated $4 billion to $5 billion per year in extra costs to the U.S. healthcare system.

"The incoming Administration and the new head of the FDA need to examine the overuse of antibiotics on factory farms. They must take the advice of the doctors and other public health professionals who have raised the alarm about antibiotic misuse and put the health of people - particularly susceptible groups like the elderly and children - ahead of industry profits. Change cannot come soon enough."

    For more information contact:
    Dan Klotz, 202-887-8855


'/>"/>
SOURCE Pew Charitable Trusts
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
3. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
4. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
5. Statement by Oscar S. Wyatt, Jr.
6. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
7. Pelosi Statement on Proposed Entitlement Task Force
8. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
9. Statement on House/Senate Agreement on SCHIP Legislation
10. Statement from the Alliance for Quality Nursing Home Care
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma Research ... lymphoma research and serving the lymphoma community through a comprehensive series of education ... Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on Monday, February 8, ...
(Date:2/12/2016)... ... 2016 , ... As a former television executive, owner Tal Rabinowitz knows how ... to decompress, Rabinowitz found herself drawn to a casual meditation class while working at ... life, implementing a 20-minute-per-day meditation practice with her team. After her tenure at NBC, ...
(Date:2/12/2016)... ... 12, 2016 , ... Itopia, a leader in cloud services ... Intelligence Platform (CIP) into Cielo®, a discovery, migration and cloud orchestration engine. This ... small and medium business (SMB) clients. , In recent years, BI ...
(Date:2/12/2016)... Arlington, TX (PRWEB) , ... February 12, 2016 , ... ... Worth, and other communities across eastern Texas, is launching a cooperative charity drive with ... and families. , Serving more than 50,000 individuals and families in need, the Tarrant ...
(Date:2/12/2016)... ... ... Donor Network West, the organ procurement organization that heals lives through organ ... Regional Medical Center. Under the collaboration, the first of its kind, specific organ donors ... certain time frame for donor families for the recovery of organs. , Organ ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... -- Eli Lilly and Company (NYSE: LLY ) today announced ... vitamin regimen patent would not presently be infringed by Actavis ... , Italy and Spain ... dextrose solution.  --> --> ... held that Lilly,s patent would be indirectly infringed by Actavis ...
(Date:2/12/2016)... 2016  Apellis Pharmaceuticals, Inc., today announced ... Series D preferred stock financing, co-led by ... Group and venBio Global Strategic Fund, joining ... Investment, and Epidarex Capital. The proceeds of the ... clinical trials in the Company,s ongoing complement ...
(Date:2/11/2016)... , Feb. 11, 2016 The primary ... and future adoption patterns on the usage of liquid ... the following: - Timeframe of liquid biopsy ... ctDNA, cfDNA and Evs—by organization type - Sample inflow ... types: blood, saliva, stool, serum, and so on. - ...
Breaking Medicine Technology: